Long-Read Metagenomics Market Global Report 2026

The long-read metagenomics market size has grown exponentially in recent years. It will grow from $1.79 billion in 2025 to $2.16 billion in 2026 at a compound annual growth rate (CAGR) of 21.1%. The growth in the historic period can be attributed to decline in dna sequencing costs, expansion of next generation sequencing platforms, growth in microbiome research studies, increased funding for genomic research programs, development of early metagenomic assembly tools.

The long-read metagenomics market size is expected to see exponential growth in the next few years. It will grow to $4.69 billion in 2030 at a compound annual growth rate (CAGR) of 21.3%. The growth in the forecast period can be attributed to adoption of precision medicine approaches, expansion of clinical metagenomics diagnostics, rise in real time pathogen monitoring systems, integration of ai driven genomic analytics, increased demand for portable sequencing solutions. Major trends in the forecast period include high-resolution microbial strain resolution using long-read sequencing, advanced error correction and polishing algorithms for metagenomic assemblies, real-time pathogen surveillance through environmental dna sequencing, ultra-deep metagenomic profiling for rare species detection, improved sample preparation techniques for high molecular weight dna extraction.

The increasing burden of infectious diseases is expected to accelerate the growth of the long-read metagenomics market in the coming years. Infectious diseases are illnesses caused by disease-causing microorganisms, including bacteria, viruses, fungi, and parasites, which can spread through direct or indirect transmission among humans, animals, or environmental sources. The growing prevalence of infectious diseases is attributed to the emergence of antimicrobial-resistant pathogens and the increasing occurrence of worldwide disease outbreaks. Long-read metagenomics contributes to infectious disease control by allowing accurate detection of pathogens, identification of antimicrobial resistance genes, and analysis of genomic variations from complex clinical and environmental samples in real time. Long-read metagenomics enhances disease surveillance, supports rapid pathogen identification, and improves epidemiological monitoring within healthcare and public health systems. For instance, in October 2024, according to the World Health Organization (WHO), a Switzerland-based intergovernmental public health organization, around 8.2 million people were newly diagnosed with tuberculosis in 2023, compared with 7.5 million cases in 2022. Therefore, the increasing prevalence of infectious diseases is driving the growth of the long-read metagenomics market.

Key companies operating in the long-read metagenomics market are focusing on developing advanced solutions, such as AI-powered genomic analysis platforms, to improve variant detection accuracy, automate complex sequence interpretation, and reduce downstream bioinformatics costs. AI-powered genomic analysis platforms are advanced computational systems that combine machine learning algorithms with long-read sequencing data to identify structural genomic variations, reconstruct plasmids, and deliver high-resolution microbial characterization with greater speed and precision. For example, in February 2024, PacBio, a US-based biotechnology company specializing in long-read sequencing technologies, launched the HiFi Prep Kit 96 and HiFi Plex Prep Kit 96 for its Revio sequencing system. The new high-throughput library preparation solutions were designed to accelerate long-read sequencing workflows for microbial and metagenomic applications. The kits enable automated sample preparation, improved scalability, reduced workflow time, and lower sequencing costs while supporting high accuracy. HiFi long-read sequencing supports complex metagenome assembly and microbial community analysis.

In July 2024, Oxford Nanopore Technologies, a UK-based biotechnology company specializing in nanopore-based long-read sequencing technologies, partnered with Plasmidsaurus to broaden the application of nanopore-based long-read sequencing across microbial genomics, plasmid analysis, and metagenomic sequencing workflows. The collaboration was intended to enhance sequencing accuracy, improve scalability, strengthen microbial genome assembly, and enable faster characterization of complex microbial communities for advanced metagenomics research and clinical applications. Plasmidsaurus is a US-based sequencing company specializing in plasmid, microbial, and long-read sequencing services.

Major companies operating in the long-read metagenomics market report are Illumina Inc., QIAGEN N.V., BGI Genomics Co. Ltd., Novogene Co. Ltd., Oxford Nanopore Technologies plc, Pacific Biosciences of California Inc., New England Biolabs Inc., MGI Tech Co. Ltd., Element Biosciences Inc., Zymo Research Corporation, CD Genomics, Plasmidsaurus Inc., BaseClear B.V., Nucleome Informatics Private Limited, Sage Science Inc., MicrobesNG Ltd., Phase Genomics Inc., Universal Sequencing Technology Corporation, Biolome Inc., Thermo Fisher Scientific Inc., 10x Genomics Inc., Revvity Inc., Azenta US Inc., Takara Bio Inc.

North America was the dominating region in the long-read metagenomics market in 2025. Asia-Pacific is expected to be the rapidly growing region in the forecast period. The regions covered in the long-read metagenomics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the long-read metagenomics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The long-read metagenomics consists of revenues earned by entities by providing services such as metagenomic sequencing, high-throughput hybrid sequencing, sample processing, de novo assembly, structural variant identification, native epigenetic modification mapping, real-time adaptive sequencing, and custom bioinformatics analysis. The market value includes the value of related goods sold by the service provider or included within the service offering. The long-read metagenomicss market also includes sales of sequencing instruments, sequencing chips, automated library preparation kits, and high-molecular-weight (HMW) DNA extraction kits. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

This product will be delivered within 3-5 business days.